Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porterโs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Rheumatic Fever Market, by Diagnosis
6.1 Introduction
6.2 Physical Exam
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
6.3 Blood Test
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
6.4 Electrocardiogram (ECG)
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
6.5 Echocardiogram
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
Chapter 7. Global Rheumatic Fever Market, by Treatment
7.1 Introduction
7.2 Pharmacotherapy
7.2.1 Antibiotics
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
7.2.2 Anti-Inflammatory Medication
7.2.2.1 Aspirin
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
7.2.2.2 Naproxen
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
7.2.2.3 Others
7.2.3 Anticonvulsant Medication
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
7.2.4 Others
7.3 Others
Chapter 8. Global Rheumatic Fever Market, by Distribution Channel
8.1 Introduction
8.2 Retail Pharmacies
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.3 Hospital Pharmacies
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.4 Others
Chapter 9. Global Rheumatic Fever Market, by End-User
9.1 Introduction
9.2 Hospital and Clinics
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
9.3 Diagnostic Centers
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
9.4 Others
Chapter 10. Global Rheumatic Fever Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
Chapter 11. Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
Chapter 12. Company Profiles
12.1 Bayer AG
12.1.1 Company Overview
12.1.2 Product Overview
12.1.3 Financials Overview
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.2 Abbott Laboratories
12.2.1 Company Overview
12.2.2 Product Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Johnson & Johnson Services, Inc.
12.3.1 Company Overview
12.3.2 Product Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 F. Hoffmann-La Roche Ltd.
12.4.1 Company Overview
12.4.2 Product Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 Novartis AG
12.5.1 Company Overview
12.5.2 Product Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.6 Pfizer, Inc.
12.6.1 Company Overview
12.6.2 Product Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.7 Bristol-Myers Squibb Company
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financial Overview
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 AstraZeneca
12.8.1 Overview
12.8.2 Product Overview
12.8.3 Financials
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.9 Valeant Pharmaceuticals International, Inc.
12.9.1 Overview
12.9.2 Product Overview
12.9.3 Financials
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.10 Eli Lily and Company
12.10.1 Overview
12.10.2 Product Overview
12.10.3 Financials
12.10.4 Key Developments
12.10.5 SWOT Analysis
Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEOโs Viewpoint
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Predictions for the Rheumatic Fever Industry
Chapter 14. Appendix
LIST OF TABLES
Table 1 Global Rheumatic Fever Market Synopsis, 2020โ2027
Table 2 Global Rheumatic Fever Market Estimates and Forecast, 2020โ2027 (USD Million)
Table 3 Global Rheumatic Fever Market, by Region, 2020โ2027 (USD Million)
Table 4 Global Rheumatic Fever Market, by Diagnosis, 2020โ2027 (USD Million)
Table 5 Global Rheumatic Fever Market, by Treatment, 2020โ2027(USD Million)
Table 6 Global Rheumatic Fever Market, by Distribution Channel, 2020โ2027 (USD Million)
Table 7 Global Rheumatic Fever Market, by End-User, 2020โ2027 (USD Million)
Table 8 North America: Rheumatic Fever Market, by Diagnosis, 2020โ2027 (USD Million)
Table 9 North America: Rheumatic Fever Market, by Treatment, 2020โ2027 (USD Million)
Table 10 North America: Rheumatic Fever Market, by Distribution Channel, 2020โ2027 (USD
Million)
Table 11 North America: Rheumatic Fever Market, by End-User, 2020โ2027 (USD Million)
Table 12 US: Rheumatic Fever Market, by Diagnosis, 2020โ2027 (USD Million)
Table 13 US: Rheumatic Fever Market, by Treatment, 2020โ2027 (USD Million)
Table 14 US: Rheumatic Fever Market, by Distribution Channel, 2020โ2027 (USD Million)
Table 15 US: Rheumatic Fever Market, by End-User, 2020โ2027 (USD Million)
Table 16 Canada: Rheumatic Fever Market, by Diagnosis, 2020โ2027 (USD Million)
Table 17 Canada: Rheumatic Fever Market, by Treatment, 2020โ2027 (USD Million)
Table 18 Canada: Rheumatic Fever Market, by Distribution Channel, 2020โ2027 (USD Million)
Table 19 Canada: Rheumatic Fever Market, by End-User, 2020โ2027 (USD Million)
Table 20 South America: Rheumatic Fever Market, by Diagnosis, 2020โ2027 (USD Million)
Table 21 South America: Rheumatic Fever Market, by Treatment, 2020โ2027 (USD Million)
Table 22 South America: Rheumatic Fever Market, by Distribution Channel, 2020โ2027 (USD
Million)
Table 23 South America: Rheumatic Fever Market, by End-User, 2020โ2027 (USD Million)
Table 24 Europe: Rheumatic Fever Market, by Diagnosis, 2020โ2027 (USD Million)
Table 25 Europe: Rheumatic Fever Market, by Treatment, 2020โ2027 (USD Million)
Table 26 Europe: Rheumatic Fever Market, by Distribution Channel, 2020โ2027 (USD Million)
Table 27 Europe: Rheumatic Fever Market, by End-User, 2020โ2027 (USD Million)
Table 28 Western Europe: Rheumatic Fever Market, by Diagnosis, 2020โ2027 (USD Million)
Table 29 Western Europe: Rheumatic Fever Market, by Treatment, 2020โ2027 (USD Million)
Table 30 Western Europe: Rheumatic Fever Market, by Distribution Channel, 2020โ2027 (USD
Million)
Table 31 Western Europe: Rheumatic Fever Market, by End-User, 2020โ2027 (USD Million)
Table 32 Eastern Europe: Rheumatic Fever Market, by Diagnosis, 2020โ2027 (USD Million)
Table 33 Eastern Europe: Rheumatic Fever Market, by Treatment, 2020โ2027 (USD Million)
Table 34 Eastern Europe: Rheumatic Fever Market, by Distribution Channel, 2020โ2027 (USD
Million)
Table 35 Eastern Europe: Rheumatic Fever Market, by End-User, 2020โ2027(USD Million)
Table 36 Asia-Pacific: Rheumatic Fever Market, by Diagnosis, 2020โ2027 (USD Million)
Table 37 Asia-Pacific: Rheumatic Fever Market, by Treatment, 2020โ2027 (USD Million)
Table 38 Asia-Pacific: Rheumatic Fever Market, by Distribution Channel, 2020โ2027 (USD Million)
Table 39 Asia-Pacific: Rheumatic Fever Market, by End-User, 2020โ2027 (USD Million)
Table 40 Middle East & Africa: Rheumatic Fever Market, by Diagnosis, 2020โ2027
(USD Million)
Table 41 Middle East & Africa: Rheumatic Fever Market, by Treatment, 2020โ2027 (USD Million)
Table 42 Middle East & Africa: Rheumatic Fever Market, by Distribution Channel, 2020โ2027
(USD Million)
Table 43 Middle East & Africa: Rheumatic Fever Market, by End-User, 2020โ2027 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Rheumatic Fever Market
Figure 3 Segmentation Market Dynamics for Global Rheumatic Fever Market
Figure 4 Global Rheumatic Fever Market Share, by Diagnosis, 2020
Figure 5 Global Rheumatic Fever Market Share, by Treatment, 2020
Figure 6 Global Rheumatic Fever Market Share, by Distribution Channel, 2020
Figure 7 Global Rheumatic Fever Market Share, by End-User, 2020
Figure 8 Global Rheumatic Fever Market Share, by Region, 2020
Figure 9 North America: Rheumatic Fever Market Share, by Country, 2020
Figure 10 Europe: Rheumatic Fever Market Share, by Country, 2020
Figure 11 Asia-Pacific: Rheumatic Fever Market Share, by Country, 2020
Figure 12 Middle East & Africa: Rheumatic Fever Market Share, by Country, 2020
Figure 13 Global Rheumatic Fever Market: Company Share Analysis, 2020 (%)
Figure 14 Bayer AG: Key Financials
Figure 15 Bayer AG: Segmental Revenue
Figure 16 Bayer AG: Geographical Revenue
Figure 17 Abbott Laboratories: Key Financials
Figure 18 Abbott Laboratories: Segmental Revenue
Figure 19 Abbott Laboratories: Geographical Revenue
Figure 20 Johnson & Johnson Services, Inc.: Key Financials
Figure 21 Johnson & Johnson Services, Inc.: Segmental Revenue
Figure 22 Johnson & Johnson Services, Inc.: Geographical Revenue
Figure 23 F. Hoffmann-La Roche Ltd.: Key Financials
Figure 24 F. Hoffmann-La Roche Ltd.: Segmental Revenue
Figure 25 F. Hoffmann-La Roche Ltd.: Geographical Revenue
Figure 26 Novartis AG: Key Financials
Figure 27 Novartis AG: Segmental Revenue
Figure 28 Novartis AG. Geographical Revenue
Figure 29 Pfizer, Inc.: Key Financials
Figure 30 Pfizer, Inc.: Segmental Revenue
Figure 31 Pfizer, Inc.: Geographical Revenue
Figure 32 Bristol-Myers Squibb Company: Key Financials
Figure 33 Bristol-Myers Squibb Company: Segmental Revenue
Figure 34 Bristol-Myers Squibb Company: Geographical Revenue
Figure 35 AstraZeneca: Key Financials
Figure 36 AstraZeneca: Segmental Revenue
Figure 37 AstraZeneca: Geographical Revenue
Figure 38 Valeant Pharmaceuticals International, Inc.: Key Financials
Figure 39 Valeant Pharmaceuticals International, Inc.: Segmental Revenue
Figure 40 Valeant Pharmaceuticals International, Inc.: Geographical Revenue
Figure 41 Eli Lily and Company: Key Financials
Figure 42 Eli Lily and Company: Segmental Revenue
Figure 43 Eli Lily and Company: Geographical Revenue
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
ยฉ 2024 Market Research Future ยฎ (Part of WantStats Reasearch And Media Pvt. Ltd.)
